Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chaigetuire Keli for common cold (wind-cold with interior heat) – phase IIb RCT
CTR20254583Phase 2Completed
- Sponsor
- Kaijin Biotech
- Start
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of Chaigetuire Keli in nasopharyngitis, sponsored by Kaijin Biotech. Started Dec 2025; status: completed.
02
Drugs
Chaigetuire Keli
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20254583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254583.